Effects of recombinant plasminogen activator inhibitor type 1 on fibrinolysis in vitro and in vivo

Thrombosis Research
R M KnabbT M Reilly

Abstract

A biologically active recombinant PAI-1 (rPAI-1) was evaluated for its effects on clot lysis in vitro and in vivo. At concentrations of 0.5 to 10 micrograms/ml, the rPAI-1 significantly prolonged the time to lysis of rabbit euglobulin clots both in the presence and absence of exogenous tissue plasminogen activator. To examine the effects of PAI in vivo, we infused rPAI-1 into conscious rabbits after i.v. injection of homogenized fibrin clots, and assessed fibrinolysis by measuring the appearance of d-dimer fibrin degradation products (FDP). Plasma fibrinolytic activity, PAI activity and antigen were also measured in plasma samples taken during and after infusion of rPAI-1. In control rabbits, endogenous fibrinolytic activity resulted in a significant and continual generation of FDP, reaching 32.6 +/- 13.6 ng/ml 90 minutes after fibrin injection. Infusion of 1, 2, or 5 micrograms/kg/min rPAI-1 led to dose dependent increases in PAI activity and antigen, while FDP levels at 90 minutes were only 8.8 +/- 2.9, 5.7 +/- 2.4, and 0.3 +/- 0.3 ng/ml, respectively. Complete inhibition of fibrinolysis was observed with 10 micrograms/kg/min rPAI-1. These studies directly demonstrate that increases in PAI-1 impair the fibrinolytic system, an...Continue Reading

Citations

Jan 1, 1995·International Journal of Clinical & Laboratory Research·D PriscoG F Gensini
Feb 1, 1994·Alcoholism, Clinical and Experimental Research·P R Eisenberg
Aug 1, 1992·Annals of the Rheumatic Diseases·E J BrommerF C Breedveld
Jan 11, 2000·QJM : Monthly Journal of the Association of Physicians·F De LorenzoV V Kakkar
May 1, 1997·Expert Opinion on Investigational Drugs·P Charlton
Jan 13, 2005·The Annals of Pharmacotherapy·Muhammad U FarooqArshad Majid
Sep 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·C F ReillyM E Siegfried
Apr 18, 1994·Annals of the New York Academy of Sciences·D J LoskutoffR Schleef

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.